Differential in vitro inhibition of thrombin generation by anticoagulant drugs in plasma from patients with cirrhosis.
<h4>Background</h4>Treatment and prevention of thrombotic complications is frequently required in patients with cirrhosis. However anticoagulant therapy is often withheld from these patients, because of the perceived bleeding diathesis. As a result of the limited clinical experience, the...
Guardado en:
Autores principales: | Wilma Potze, Freeha Arshad, Jelle Adelmeijer, Hans Blokzijl, Arie P van den Berg, Joost C M Meijers, Robert J Porte, Ton Lisman |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ab5c946e84b14f6f9c4891e1f2c3c61f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Anticoagulation in Patients with Liver Cirrhosis (Literature Review)
por: E. S. Eniseeva
Publicado: (2019) -
The in vitro addition of idarucizumab to plasma samples from patients increases thrombin generation
por: Mojca Božič Mijovski, et al.
Publicado: (2021) -
Role of a thrombin generation assay in the prediction of infection severity
por: Boaz Elad, et al.
Publicado: (2021) -
Aggravation of fibrin deposition and microthrombus formation within the graft during kidney transplantation
por: Tamar A. J. van den Berg, et al.
Publicado: (2021) -
Prognostic value of thrombin generation parameters in hospitalized COVID-19 patients
por: María Eugenia de la Morena-Barrio, et al.
Publicado: (2021)